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Summary
To defend against pulmonary infections, lung epithelial cells are equipped with complex innate 
immunity closely linked to inflammation. Dysregulated innate immunity / inflammation leads to 
self-perpetuating lung injury. The CpG motif in bacterial DNA is one of the factors involved in 
bacterial infection-associated inflammation. Bacterial DNA and synthetic CpG oligonucleotide 
(ODN) induced CCN1 secretion from lung epithelial cells, functioning as a potential “braking” 
signal to prevent uncontrolled inflammatory responses. CpG ODN-induced ER stress resulted in 
Src-Y527 phosphorylation (pY527) and Src/CCN1 vWF domain dissociation. Src-Y527 activated 
caveolin-1 (cav-1) phosphorylation at Y14 and then modulated CCN1 secretion via pCav-1 
interaction with CCN1 IGFbp domain. Functionally, secreted CCN1 promoted anti-inflammatory 
cytokine IL-10 release from epithelial cells via integrin αVβ6 PKC, and this subsequently 
suppressed TNF-α, MIP-2 secretion and neutrophil infiltration in the lungs. Collectively, bacterial 
DNA/CpG ODN-stimulated CCN1 secretion via BiP/GRP78-Src(Y527)-JNK-Cav-1(Y14) 
pathway and CpG-induced CCN1 conferred anti-inflammatory roles. Our studies suggested a 
novel paradigm by which the lung epithelium maintains innate immune homeostasis after bacterial 
infection.
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Introduction
Lung epithelial cells are essential component of the airway physiological barrier and the 
first-line innate immunity to microbial pathogens.1,2 One of the most important innate 
immune function of lung epithelial cells is to recruit immune cells to the lung micro-
environment to maintain homeostasis.1,2 Lung epithelial cells directly recognize the 
pathogen-associated molecular patterns (PAMPs) via Toll like receptors (TLRs) to initiate 
and amplify the innate immune responses needed for pathogen clearance during infection.3,4 
Unmethylated CpG motifs are mostly present in bacterial DNA but not in human genomic 
DNAs.5-8 CpG motifs in oligodeoxynucleotides (ODN) activate host innate and acquired 
immune responses via TLR9 receptor-mediated mitogen activated protein kinases (MAPKs) 
and NFκB pathways, not only in immune cells, but also in epithelial cells.5-7 The innate 
immunity is closely linked to inflammatory responses that include robust release of 
inflammatory cytokines/chemokines, which play a crucial role in bactericidal effects.9,10 
However, dysregulated innate immunity and inflammatory responses can lead to damage of 
lung parenchyma, resulting in acute lung injury (ALI) and contributing to significant 
mortality and morbidity.11 Therefore, a self-limiting or “braking” system in host epithelium 
is needed to prevent this ‘runaway’ inflammation and maintain lung microenvironment 
homeostasis after microbial infections.
The IL-10 family cytokines derived from immune cells and lung epithelial cells are essential 
for maintaining the integrity and homeostasis of lung epithelium via limiting the lung injury 
caused by bacterial infection-associated inflammation.12,13 For example, the neutrophil 
counts in bronchoalveolar lavage fluid (BALF) and blood are much higher in IL-10 KO 
mice than wild-type mice. Furthermore, neutrophil infiltration and excessive inflammation 
are found in IL-10 KO mice, suggesting that the high mortality in IL-10 KO mice is 
associated with exaggerated inflammation.14 However, in a model of pre-existing sepsis 
followed by Pseudomonas aeruginosa pneumonia (“two-hit” model), inhibition of IL-10 
improved survival and clearance of bacteria15, suggesting a central role of IL-10 in the fine 
balance of bactericidal /innate immunity and tissue-damaging inflammation.16 Therefore, it 
is important to understand the regulatory machinery on lung epithelial cell-mediated 
homeostasis and innate immunity in response to bacterial infection. In our current report, we 
investigated a novel paradigm on how lung epithelial cells self-limit the potential ‘runaway’ 
inflammation after bacterial infection via the regulation of pro-inflammatory and 
immunosuppressive cytokines.
CCN1 (Cyr61) is an immediate early response gene product ubiquitously expressed in lung 
cells, particularly in lung epithelial cells.17-20 CCN1 is secreted into the extracellular matrix 
(ECM) after stimulation by various stimuli and exhibits diverse cellular functions in a 
paracrine/autocrine manner.18 CCN1 plays diverse roles such as cell repair, tissue 
remodeling, cell migration, differentiation, proliferation, apoptosis and senescence.18 
Studies in animal models have confirmed that disruption of CCN1 is embryonic lethal21 and 
deregulation of CCN1 is involved in various pathologies related to inflammation and tissue 
repair.18 However, despite ubiquitous expression in lung parenchyma, its secretion and 
function in lung diseases remain unexplored. Our current studies investigated the secretion 
and function of CCN1 in response to bacterial infection. We further delineated the pathways 
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involved in CCN1 secretion and the underlying mechanisms by which CCN1 confers its 
cellular and protective functions in lung epithelial cells during infection.
Results
Bacterial DNA and its synthetic motif CpG ODN induced CCN1 secretion from lung 
epithelial cells
In vivo studies initially demonstrated that intranasal K. pneumoniae (103 CFU/mouse) 
infection rapidly increased CCN1 release in BALF and peaked around 24h after stimulation 
(Fig. 1A). We also stimulated the lung epithelial cells using bacterial genomic DNA 
obtained from K.pneumoniae, A.bauminnii and P.aerosinosa (Fig. 1B). Bacterial DNAs 
rapidly augmented the CCN1 secretion from cultured Beas2B epithelial cells 4h after 
stimulation (Fig. 1B). Given the critical roles of TLRs in mediating lung bacterial infection 
and inflammation, we next assessed the effects of TLR agonists on CCN1 secretion in 
epithelial cells. Class C TLR9 agonist, CpG ODN 2395, induced a robust CCN1 secretion in 
three different epithelial cells, in a dose- and time-dependent manner (Fig. 1C, S1A-B). 
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria than of 
humans.24 CpG ODNs are synthetic unmethylated bacterial DNA motif containing CpG 
dinucleotides which activate TLR9-mediated pathways.22,23 We found that all three major 
classes of stimulatory CpG ODNs (ODN2336, 2006 and 2395) increased the CCN1 
secretion (Fig. S1C) and class C expressed the strongest effects on induction of CCN1 
secretion (Fig. S1C). Interestingly, although CpG ODNs are well known TLR9 agonists, 
TLR9 silencing by siRNA and inhibition of NF-κB pathway by Bay11-7082 had no 
significant effects on CCN1 secretion (Fig. S1D-E), suggesting that the CpG ODN-induced 
CCN1 secretion was TLR9-independent. To determine the temporal dynamics of CCN1 
secretion from lung epithelial cells after bacterial DNA/CpG ODNs, we evaluated the CCN1 
protein level at various time points by ELISA. Majority of CCN1 were secreted within 1h 
after ODN stimulation (Fig. 1D). Furthermore, we collected the supernatant of Beas2B cells 
after stimulation with ODN. Exosome and soluble fraction were isolated using 
ultracentrifugation. We found that the majority of matrix CCN1 was secreted via soluble 
forms, rather than in exosome-encapsulated forms (Fig. 1E). To test CpG ODN-induced 
CCN1 secretion in vivo, we delivered ODN 2395 intranasally to mice. Consistently, ODN 
2395 enhanced CCN1 level in mouse BAL fluid (BALF) in a dose-dependent manner (Fig. 
1F). All the above observations supported that bacterial DNA/CpG ODN-stimulated CCN1 
secretion from lung epithelial cells in soluble forms as an immediate early response to 
microbial infection/stimulation. These results prompted us to explore the functional roles of 
secreted CCN1 in lungs after bacterial infection.
Bacterial DNA/CpG ODN–induced CCN1 secretion conferred anti-inflammatory effects both 
in vitro and in vivo
To explore the functions of CCN1 in bacterial lung infection-associated inflammation in 
vivo, we first used LPS-induced inflammation model in mice. We administrated intranasally 
CCN1 or ODN with and without LPS. The CCN1 or ODN was delivered at the same time 
along with LPS, and BAL fluid was collected after 24h. Differential cell counts including 
neutrophils and macrophages were conducted after Diff-Quick staining. We showed that co-
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treatment with either ODN or CCN1 with LPS attenuated the LPS-induced neutrophil 
infiltration, assessed by neutrophil count in BALF (Fig. 2A) and lung tissue (Fig. 2B). 
Macrophage inflammatory protein 2 (MIP-2), a chemokine which attracts neutrophils and 
normally has its secretion enhanced by bacterial infection-associated inflammation, was also 
enhanced by LPS. However, this effect was abolished after addition of ODN or CCN1 (Fig. 
2C). TNF-α is a well-known inflammatory mediator of sepsis-induced lung injury.24,25 
IL-10, on the contrary, represses pro inflammatory responses in lungs.26 Both ODN and 
CCN1 suppressed LPS-induced TNF-α, but up regulated the IL-10 level in BALF in both 
the absence or presence of LPS (Fig. 2D). Furthermore, co-treatment of bioactive CCN1 
recombinant protein reduced the LPS-induced TNF-α and IL 6 secretion from alveolar 
macrophages in a dose-dependent manner (Fig. S2A).
To test whether the above effects of ODN were triggered by the induction of CCN1 
secretion, we administered anti-CCN1 antibodies in ODN/LPS treated mice. ODN alone 
blocked the LPS induced neutrophil accumulation in BAL. Neutralization of CCN1 
abolished the effects of ODN, resulted in significantly higher neutrophil counts in both BAL 
and lung tissues (Fig. 2E-F). Consistent with observations on neutrophil cell numbers and 
differentiations detected in BAL, neutralization of CCN1 notably reversed the inhibitory 
effects of ODN on LPS-induced TNF-α and MIP-2 level in BALF (Fig. 2G-H). We next 
confirmed this observation in vitro using alveolar macrophages. Neutralization of CCN1 
using anti-CCN1 antibodies consistently reversed the effects of ODN on LPS activated 
alveolar macrophages, as determined by both IL-6 and TNF-α level (Fig. S2B). 
Furthermore, lung histological examination suggested that LPS-induced inflammation was 
reduced after ODN treatment. Anti-CCN1 antibodies reversed the anti-inflammatory effects 
of ODN (Fig. 2I).
CCN1 promoted IL-10 secretion via integrin αVβ6-mediated pathways
To determine which cells secreted IL-10 after CCN1 treatment, we isolated primary mouse 
alveolar macrophages and epithelial cells. CCN1 and ODN both induced IL-10 production, 
either alone or synergistically with LPS in primary type II lung epithelial cells, but not in 
alveolar macrophages (Fig. 3A). In human A549 lung epithelial cells, CCN1-induced IL-10 
secretion in a dose-dependent manner (Fig. S3A). Previous reports have suggested that 
integrin αVβ6 affects IL-10 secretion in other disease models.27 Therefore, we assessed the 
expression of integrin αVβ6 in lung epithelial cells after CCN1 stimulation. We found that 
CCN1-induced the expression of both integrin αV and β6 (Fig. S3B). Blocking integrin 
αVβ6 using neutralizing antibodies prevented CCN1-induced IL-10 release from primary 
mouse lung type II epithelial cells (Fig. 3B). Furthermore, we confirmed that CCN1 induced 
IL-10 expression was down-regulated after integrin αVβ6 neutralization in lung tissue by 
immunofluorescence (Fig. 3C). To confirm the importance of integrin αVβ6 in mediating 
ODN/CCN1-induced IL-10 secretion, we administrated anti integrin αVβ6 antibodies 
intranasally with either ODN or CCN1 into mice. Neutralization of integrin αVβ6 reversed 
the inhibitory effects of both ODN and CCN1 on LPS-induced neutrophil infiltration and 
TNF-α level in BALF (Fig. 3D E). We next evaluated the down stream signaling pathways 
of integrin αVβ6 which potentially mediated the effects of CCN1 on IL-10 secretion. 
Inhibitors were used for various signaling pathways; Bay11-7082 for NK-κB, U0126 for 
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MEK, JNK II inhibitor for JNK, Y27632 for p160 ROCK, watmannin for PI3K, SB 203580 
for p38 MAPK and GO6850 for PKC. Cells were pre-treated with each inhibitor (10 μM) 1h 
prior to the treatment of CCN1 recombinant protein (1 μg/ml). We found that only GO6850 
(PKC inhibitor) blocked CCN1-induced IL-10 secretion (Fig. 3F). Taken together, CpG 
ODN-induced CCN1 augmented IL-10 secretion via integrin αVβ6 – PKC pathway in lung 
epithelial cells
Cav-1 phosphorylation was crucial in regulating CCN-1 secretion
Our previous report suggests that Cav-1 is involved in the regulation of CCN1 secretion 
after oxidative stress.28 In this current study, we found that ODN promoted Cav-1 
phosphorylation at Y14 in a time-dependent manner (Fig. 4A). Next, we isolated primary 
type II lung epithelial cells from WT and Cav-1−/− mice and stimulated these cells with 
ODN. CCN1 secretion and expression in Cav-1−/− cells were remarkably reduced compared 
to similarly treated WT cells (Fig. 4B). Pretreatment of daidzein, a Cav-1 inhibitor29, 
suppressed the ODN-stimulated CCN1 secretion in a dose-dependent manner as well (Fig. 
S4A). Consistently, over-expression of Cav-1 in Beas2B cells augmented CCN1 secretion 
(Fig. S4B). Using co-immunoprecipitation (Co-IP) assays, we demonstrated that CCN1 
interacted with pCav-1 at a peak time between 15 min to 45 mins. This interaction 
dissociated after 60 min (Fig. 4C). The co-localization between CCN1 and pCav-1 was 
detected after ODN treatment (Fig. 3D). CCN1 protein consists of five specific domains 
(SP, IGFbp, vWF, TSP and CT) and each domain carries different protein binding motifs.18 
To determine the specific binding domain for pCav-1/CCN1 interactions, we generated 
specific domain-depleted CCN1 constructs and transfected them into Beas2B cells. For each 
construct, one specific domain was deleted. The interactions between p-Cav-1 and CCN1 
were diminished in the absence of domain 2 (IGFbp domain), suggesting that IGFbp is a 
crucial binding site of pCav-1 (Fig. 4E). To confirm the effects of Cav-1 on CCN1 secretion 
in vivo, we administrated LPS with/without ODN intranasally into WT and Cav-1−/− mice. 
Deletion of Cav-1 reversed the ODN-suppressed neutrophil infiltration (Fig. 4F) and 
reversed the effects of ODN of both TNF-α and IL-10 secretion (Fig. 4G). These results 
indicated that pCav-1 regulated CCN1 secretion and that pCav-1/IGFbp domain interaction 
was crucial in mediating CCN1 secretion.
Cav-1 phosphorylation and CCN1 secretion were regulated by Src activation at Y527
We have shown that pCav-1 was crucial to CCN1 secretion. Previous report shows that the 
phosphorylation of Cav-1 is triggered by Src tyrosine kinase.30 Therefore, we assessed the 
expression of Src, Src-Y416 and Src-Y527 in Beas2B cells after ODN stimulation. 
Expression of Src-Y416 and Src-Y527 were increased within 5 min after ODN treatment 
(Fig. 5A). Deletion of Src reduced pCav-1 (Fig. 5B) and CCN1 secretion (Fig. 5C), 
suggesting that Src is important in the Cav-1-mediated CCN1 secretion. Next, to investigate 
whether the phosphorylation of Src is crucial in CCN1 secretion, we pre-treated Beas2B 
cells with Src phosphorylation inhibitor (PP2). PP2 suppressed Src phosphorylation at 
tyrosine 416 (Src-Y416) and 527 (Src-Y527), as well as Cav-1 phosphorylation (pCav-1) 
(Fig. 4D) and CCN1 secretion (Fig. 5E). To determine the relevance of Src-Y527 and Y416 
with Cav-1 phosphorylation and CCN1 secretion, we evaluated the expression of Src-Y416 
and Y527 after silencing both CCN1 and Cav-1 using siRNAs. Deletion of either CCN1 or 
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Cav-1 diminished the expression of Src-Y527 but not Y416, suggesting that Y527 is 
important in the regulation of CCN1 and Cav-1 (Fig. 4F). The interactions between pCav-1 
and Src increased in a time-dependent manner (Fig. 5G), while CCN1/Src interactions 
peaked at 15 min after ODN stimulation (Fig. 5G). Next, the domain-depleted CCN1 
constructs were transfected into Beas2B cells. Deletion of domain 3 (vWF domain) resulted 
in significant less interaction between CCN1 and Src or Src-Y527 (Fig. 5H). To confirm our 
observations in vivo, we administered LPS with or without ODN to wild type mice 
intranasally in the presence or absence of intraperitoneal PP2 treatment. ODN inhibited 
LPS-induced neutrophil infiltration in BALF; however, PP2 treatment reversed the effects of 
ODN (Fig. 5I). PP2 also reversed the regulatory effects of ODN on TNF-α and IL-10, 
detected in BALF (Fig. 5J). These results further supported the fact that Src 
phosphorylation, particularly Src-pY527, plays a crucial role in Cav-1 phosphorylation and 
CCN1 secretion after ODN stimulation in lung epithelial cells.
ER stress regulated CCN1 secretion induced by CpG ODN
To further delineate the mechanisms by which CpG ODN regulated CCN1 secretion, we 
first determined the localization of CpG ODN in major cell organelles. We found that CpG 
ODN-FITC co-localized with the ER associated protein BiP/GRP78 as observed using 
confocal microscopy (Fig. 6A). We next evaluated the effects of ODN on the expression of 
ER stress-associated proteins, including BiP/GRP78 and CCAAT-enhancer-binding protein 
homologous protein (CHOP). Expression of BiP/GRP78 or CHOP was increased at 1 min or 
3 min, respectively, after ODN stimulation (Fig. 6B). To investigate the association of ER 
stress signaling with the CCN1 secretion, we treated the Beas2B cells with chemical 
inhibitors of various ER stress pathways. JNK (JNK inhibitor), MAPK (SB203580) and NF-
κB (Bay11-7082) inhibitors were used for Ire-1-associated pathways; perk inhibitor was 
used for perk pathway and γ-secretase inhibitor for ATF6 cleavage pathway. Blocking JNK 
pathway significantly reduced the CCN1 secretion (Fig. 6C). Deletion of ER-stress protein 
BiP or JNK using siRNAs significantly suppressed the ODN-induced CCN1 secretion in 
Beas2B cells (Fig. 6D). Furthermore, deletion of ER stress associated protein BiP inhibited 
expression of pSrc-Y527, pSrc-Y416 (Fig. 6E), Cav-1 and pCav-1(Y14) (Fig. 6F). However, 
BiP expression was independent to Src and its phosphorylation (Fig. S5A-B). Inhibition of 
JNK diminished the level of pCav-1 (Fig. 6F, S5D). JNK activation (pJNK) was regulated 
by Src phosphorylation (Fig. S5E) but independent of Cav-1 (Fig. S5F). Dissociation of 
CCN1/Src was an important step for ODN-triggered CCN1 secretion, as presented in above 
data (Fig. 5). The dissociation of CCN1/Src interaction after ODN stimulation was 
suppressed by BiP depletion (Fig. 6G), suggesting the involvement of ER stress in this 
process. Taken together, ER stress is the initiator of ODN-induced CCN1 secretion, 
followed by Src-Y527 and Cav-1 phosphorylation (Fig. S6A, B), in lung epithelial cells.
Discussion
Lung epithelial cells are constantly exposed to environmental toxicants and pathogens. 
Bacterial infections trigger the acute inflammatory responses which are bactericidal but 
potentially carry consequences of tissue damage leading to lung injury.3 To maintain the 
integrity of the lung epithelium and ensure effective physiological functions, lung epithelial 
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cells are armed with ‘self-limiting’ systems to control ‘runaway’ inflammatory responses. 
Here, we identified a novel paradigm in which the homeostasis of innate immunity and 
inflammation are regulated by lung epithelial cells.
We showed that the CCN1 secretion from lung epithelial cells was robustly enhanced by 
CpG ODN/bacterial DNAs in a TLR9-independent manner. Currently, the potential 
receptors /pathways by which CpG ODN induces CCN1 secretion remain unclear and under 
further investigation. CCN1 gene expression and secretion are augmented by mechanical 
stretch, oxidative stress, growth factors and cytokines through diverse signaling pathways.18 
To eradicate the bacteria, innate immune cells generate proteolytic enzymes, radical oxygen 
and granules, while epithelial cells secrete β-defensin.31-33 During this bactericidal process, 
we suspect that bacterial DNA was leaked to ECM from the damaged bacteria. At this point, 
the leaked bacterial DNAs in ECM were recognized by the surrounding lung epithelial cells 
and triggered a signaling cascade to secret CCN1. We will further investigate the cell type-
specific bacterial clearance and bacterial DNA leakage in vitro and in vivo. This bacterial 
DNA-induced CCN1 exerted anti-inflammatory effects in a paracine/autocrine manner, 
including promoting IL-10 release, suppressing both MIP-2 and TNF-α level. Consequently, 
neutrophil infiltration, but not macrophage and dendritic cell infiltration, was inhibited in 
lung parenchyma (Not shown). Thus, CCN1 potentially functioned as a “braking” molecule 
to bacterial infection-associated lung inflammatory responses
ER stress often refers to both ER dysfunction and loss of its homeostasis in the presence of 
stressful stimuli, such as bacterial infection.34 The effects of pathogens on ER stress 
robustly affect the innate and adaptive immune responses. Previous studies have 
demonstrated that bacterial infection, particularly Gram-negative bacteria-derived LPS 
induces lung inflammation via triggering ER stress.35 Particularly, the CHOP-associated ER 
stress has been shown to participate in the pathogenesis of sepsis-associated inflammation, 
cell death and lung injury.35,36 However, how the host responds to pathogen-induced ER 
stress remains largely unclear. Interestingly, the ER stress-associated proteins (BiP, CHOP), 
besides involved in the inflammatory responses, also facilitated the secretion of CCN1 to 
matrix. In the presence of inflammatory inducers, such as bacterial DNAs and CpG ODN 
motifs, CCN1 exerts anti-inflammatory features, shown in our current studies. However, ER 
stress in lung epithelial cells can also be induced by a variety of non-infectious stimuli, such 
as cigarette smoke and hyperoxia.20,37 These environmental stimuli, such as cigarette 
smoke, are less likely to induce the similar inflammatory process after bacterial infection. In 
fact, we have shown that the cigarette smoke-induced CCN1 acts as a pro-inflammatory, 
rather than anti-inflammatory agent.20 In another example, CCN1 has been reported 
previously to promote inflammation and wound repair.38-40 In these studies, Bai et al 
demonstrated that a high dose of CCN1 (10 μg/ml) treatment leads to an up-regulation of 
pro-inflammatory cytokine/chemokine mRNAs in macrophages.38 CCN1 supports the 
adhesion of macrophages, activates NF-κB mediated transcription, and induces pro-
inflammatory cytokines which are generated by classically activated M1 macrophages.38 It 
is not surprising to us that CCN1 plays a dual role in response to the inflammation triggered 
by different stimuli. Besides inflammation, numerous reports have also demonstrated that 
CCN1 carries dual roles in cell death. CCN1 has been shown to confer cytoprotection in 
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many cell types including, but not limited to, lung epithelial cells, endothelial cells, 
intestinal epithelial cells and cardiomyocytes.18,19,41,42 On the other hand, CCN1 has also 
been reported to induce apoptosis in fibroblasts.43 One of the main explanations for the 
differential functions of CCN1 in cell death is associated with surface integrins that CCN1 
binds to. For instance, CCN1 exerts its cytoprotective effects via integrin αVβ3, while 
causing cell death via integrin α6β1.41,43 Therefore, we hypothesized that CCN1 carries 
either pro-inflammatory or anti-inflammatory effects depending on the different cell surface 
integrins. In fact, in our current studies, CCN1 exerted its anti-inflammatory functions via 
integrin αVβ6, but not integrin αVβ2 which is known to mediate pro-inflammatory effects 
of CCN1.38 Taken together, to maintain the homeostasis of lung micro-environment, it is 
very possible that CCN1 functions as an anti-inflammatory factor in response to acute 
infection phase. The timing, route and amount of CCN1 secretion triggered by the “sterile” 
ER-stress can be significantly different compared to when it is infectious pathogen-
triggered. The dual function of CCN1 may well be regulated according to multiple factors, 
including the stimuli, the cell type, the lung micro-environment and the amount of secretion. 
The detailed functions of CCN1, in response to each specific stimulus, require further 
exploration.
CCN1 promoted IL-10 release via integrin αVβ6–PKC pathway. In the promoter region of 
IL-10, there are multiple transcriptional factor binding sites which can be activated by 
CCN1. For instance, the NF-κB.44 CCN1 has been reported to exert its functions via both an 
immediate-early response resulting from direct activation of NF-κB and a delayed response 
resulting from CCN1-induced cytokines.38 Furthermore, the expression of integrin αVβ6 is 
rapidly increased in epithelial cells upon inflammation and involved in immune 
suppression.46 Importantly, previous studies demonstrate that the function of αVβ6 is 
through the activation of transforming growth factor β (TGF-β) by binding the latency 
associated peptide.47 TGF-β is known to drive the production of IL-10.48 Thrombospondin 1 
(TSP 1) has been known as one of the major activators of TCGF-β.49 More interestingly, 
there is a TSP-1 like domain (domain 3, Fig. 4E) existing in the full-length CCN1.18 
Therefore, it is possible that CCN1 also induces IL-10 via a latent / indirect pathway, via 
TSP-1 domain activated TGF-β. Furthermore, the production of IL-10 is regulated by PKCδ 
signaling after LPS stimulation in BMDM50. IL-10 is one of the major mediators involved 
in the host defense against the infection-induced inflammation.12,14 Consistently, our studies 
showed that CCN1-induced IL-10 contributed to preserve lung homeostasis by suppressing 
TNF-α, MIP-2 level and neutrophil counts in BALF (Fig. 2). However, lung epithelial cell 
probably is not the only cell type which secretes IL-10 after CpG ODN stimulation. Other 
immune cells (e.g., plasmacytoid dendritic cells) may also generate IL-10 in this 
circumstance. One of the limitations in this study is that we did not address IL-10 secretion 
from other cells.
Our studies focused on the lung epithelial cell-derived CCN1s induced by bacterial DNA or 
synthetic bacterial DNA motif in the form of CpG ODNs. One future direction will be to 
explore the direct interactions between CCN1 and bacteria, as well as the functions of CCN1 
in bacterial adherence, invasion and proliferation. Moreover, we will investigate the virus 
triggered CCN1 secretion and its function. We observed influenza and RSV infection 
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stimulated CCN1 secretion in in vivo infection model (not shown). Whether the virus-
triggered CCN1 is pro- or anti-inflammatory remains unclear. The co-existence of both 
bacterial and viral infections is a common scenario seen in upper airway infections, 
pneumonia and pneumonitis. Exploration of the role of CCN1 in this complicated process 
potentially opens a novel area for lung infection research.
In summary, our studies demonstrated a novel paradigm by which hosts maintain the fine 
balance between the innate immunity / bactericidal effects and the ‘runaway’ inflammation 
which can cause lung injury. Bacterial DNA/CpG motif triggered CCN1 secretion via ER 
stess-Src-JNK-Cav-1 pathways. These lung epithelial cell-derived CCN1s exerted anti-
inflammatory functions via promoting IL-10 and inhibiting multiple pro-inflammatory 
cytokines, as well as the neutrophil infiltrations in the lung.
Experimental procedures
Reagent
Human TLR agonist kit was purchased from Invivogen (San Diego, CA), Bay11-7082, 
daidzein, 2-bromopalmitate (2-BP) from Sigma (St. Louis, MO), LPS, SB203580, γ-
secretase inhibitor and JNK inhibitor from Calbiochem (Darmstadt, Germany), PERK 
inhibitor from EMD Milloipre (Darmstadt, Germany), recombinant human CCN1 (with 
biological activities), anti-human and anti-mouse CCN1 from R&D systems, (Minneapolis, 
MN), anti-αVβ6 antibody from abcam (Cambridge, MA), A.bauminnii, K.pneumoniae and 
P.aerosinosa DNA from ATCC (Manassas, VA).
Lung inflammation mouse model
K.pneumoniae (103 cfu) was administered intra-tracheally. Mice were sacrificed at the 
designated time points. To investigate the functional role of ODN or CCN1 in vivo, ODN 
(10 μg) or CCN1 (5 μg) was simultaneously administered with LPS (10 μg) into intra-
nasally in WT and Cav-1−/− mice. PP2 (5 mg/kg) was injected intra-peritoneally. After 24 h, 
BAL fluids were obtained. Total cell counts and differentials were analyzed as previously 
described (Moon HG et al., 2010). To detect neutrophil infiltration in lung tissue, lung 
tissues were prepared as previously described26. Neutrophil was stained with Ly6G+F4/80− 
(BD Bioscience, Franklin Lakes, New Jersey) and analyzed using Flow Cytometer.
ELISA
Human CCN1 (no cross-activity with CCN2), human IL-10, mouse TNF-α, mouse IL-10, 
mouse IL-6, mouse MIP-2 duoset ELISA were purchased from R&D systems (Minneapolis, 
MN) and mouse CCN1 ELISA (no cross-activity with CCN2) was purchased from 
MyBioSource (San Diego, CA). ELISA was performed per manufacturer’s instruction.
Western blot
Cells were harvested after cold PBS washing for twice. Cells were then re-suspended in 
RIPPA buffer with protease inhibitors (Roche, Indianapolis, IN). Total protein samples were 
fractioned using 4-12% NuPAGE gel (Invitrogen, Carlsbad, CA) and transferred to PVDF 
membranes (Bio-Rad, Hercules, CA). Membranes were blocked in 5% nonfat milk in PBST 
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for 1 hour at room temperature and then incubated with primary antibodies at 4oC overnight. 
CCN1 and β-actin antibodies were purchased from Santa Cruz (Santa Cruz, CA) and TLR9 
antibody from Sigma (St. Louis, MO), Cav-1 antibody from BD Bioscience (San Jose, CA), 
pCav-1 from Abcam (Cambridge, MA), Src, Src (Y416) and Src (527) from Cell Signaling 
Technology (Danvers, MA). Membranes were washed and incubated with appropriate 
secondary antibodies (Santa Cruz, CA). Detection was performed using the SuperSignal 
West Pico and Femto system (Pierce, IL) and exposed to Molecular Imager® chemi DocTM 
XRS+ (Bio-Rad, Hercules, CA). Normalization and relative quantification were performed 
using Image Lab software (Bio-Rad, Hercules, CA).
Immunofluoresence (IF) staining
Cells were grown on the cover slip and collected and fixed with 4% paraformaldehyde for 
30 minutes and then permeabilized by 0.5% TritonX-100 for 1 hour at room temperature. 
Cells were blocked with 5% BSA in PBS for 2h at room temperature before incubating with 
primary antibodies at 4 °C overnight. Cells were then washed three times and secondary 
fluorescein and Cy3-conjugated antibodies (Santa. Cruz, CA) were applied at 1:200 dilution 
at room temperature for 1 hour. Images were captured using Olympus Fluoview BX 61 
confocal microscope (Olympus, Center Valley, PA).
Small-interfere RNA transfection & CCN1 plasmid transfection
Human TLR9 siRNA purchased from Sigma (St. Louis, MO) and CCN1, Cav-1 siRNA 
from Santa Cruz Biotechnology (Santa Cruz, CA), Src siRNA from Origenes (Rockville, 
MD), JNK and BiP siRNA from Cell Signaling Technology (Danvers, MA) and 
INTERFERin® from Polyplus (Illkirch, FRANCE). Transfection procedure was performed 
per INTERFERin® manufacturer’s instruction.
Human CCN1 plasmid constructs were designed following pcDNA3.1/V5-His© TOPO® 
TA Expression Kit (Invitrogen, Grand Island, NY). CCN1 constructs were transfected using 
LipoD293 (SignaGen, Rockville, MD) and followed manufacturer’s instruction. Transfected 
CCN1 plasmids were detected using anti-V5 antibody (Invitrogen).
Statistics
The means of fold change in all figures were compared by using two-way analysis of 
variance to test the differences among independent samples. With p< 0.05 the difference was 
considered statistically significant. Error bars indicate standard deviation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Bacterial DNA/CpG ODN induced CCN1 secretion in lung epithelial cells
(A) Secreted CCN1 in BALF was measured using ELISA after administration of 
K.pneumoniae (103CFU/mouse) intra-nasally into C57/BL6 mice.
(B) Beas2B cells were treated with bacterial DNAs (1μg/ml). After 4h, CCN1 was measured 
using ELISA.
(C) HBE, A549 and Beas2B cells were treated with TLR agonists. After 24h, the secreted 
CCN1 was measured using ELISA. Pam3CSK4 (1 Pg/ml), HKLM (108 cells/ml), LPS-EK 
(1 μg/ml), ST-FLA (1 μg/ml), FSL-1 (1 μg/ml) and ODN2395 (1μM)
(D) Beas2B cells were treated with ODN (1 μM). After the designated time, the supernatant 
was collected and the CCN1 level was measured using ELISA.
(E) Beas2B cells were treated with ODN (1 μM). After 4h, the supernatant was collected and 
ultracentrifuged to separate the exosomes and soluble factors. CCN1 was determined in both 
portions.
(F) ODN was administered into C57/BL6 mice intra-nasally. BALF was collected after 24h. 
CCN1 was detected using ELISA.
In all Fig.s, *p < .05, compared to Sham; All Fig.s represented three independent 
experiments with identical results.
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Fig. 2. CpG ODN induced CCN1 limits neutrophil infiltration in vivo
(A) CCN1 (5 μg), ODN (10 μg) and LPS (10 μg) was administered into C57/BL6 mice intra-
nasally. After 24h, BALF was collected. Total cell counts and differentials were analyzed 
using Diff-Quick staining. *p < .05, compared to LPS
(B) Pre-treatment of ODN/CCN1 at the same dose as the above resulted in less neutrophil 
infiltration in mouse lung tissue after LPS inhalation. Markers used for neutrophils: Ly6G
+F4/80-; for alveolar macrophages: Ly6G F4/80+ and for interstitial macrophages: Ly6G
+F4/80+.
(C) C57/BL6 mice were exposed to sham, CCN1, ODN, LPS, LPS+CCN1 or LPS+ODN at 
the same dose as in (A). After 24h, MIP-2 level in BALF was measured using ELISA. *p < .
05, compared to LPS treatment
(D) TNF-α and IL-10 level in BALF were measured using ELISA. *p < .05, compared to 
Sham, **p < .05 compared to LPS
(E) Anti-CCN1 (5 μg), ODN (10 μg) and LPS (10 μg) were administered into C57/BL6 mice 
intra nasally. After 24h, BALF was collected. Total cell counts and cell differentials were 
performed using Diff-Quick staining. *p < .05, compared to LPS
(F) C57/BL6 mice were exposed to sham, LPS, ODN+LPS or anti-CCN1+ODN+LPS at the 
same dose as in (E). After 24 h, neutrophil infiltration in mouse lung tissue was analyzed 
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using flow cytometer. Markers used for neutrophils: Ly6G+F4/80−; For alveolar 
macrophages: Ly6G F4/80+; For interstitial macrophages: Ly6G+F4/80+.
(G) BAL MIP-2 level in same condition with (E). After 24h, MIP-2 level in BALF was 
measured using ELISA. *p < .05, compared to LPS+ODN
(H) TNF-α and IL-10 level in BALF were measured by ELISA. *p < .05, compared to LPS
+ODN
(I) H & E stained lung tissue in the same condition with (E) (Left panel). Lung inflammation 
was scored in 10 different spots per slide and 5 slides per group (Right panel). *p < .05, 
compared to Sham, **p < .05, compared to LPS
All Fig.s represented three independent experiments with identical results.
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Fig. 3. CCN1 promoted IL-10 secretion via integrin αVβ6-PKC pathways in lung epithelial cells
(A) Primary alveolar macrophage and type II lung epithelial cells were treated with LPS 
(100 ng/ml), CCN1 (1 μg/ml) and ODN (1 μM). IL-10 production after treatment was 
determined using ELISA *p < .05, compared to Sham, **p < .05, compared to LPS
(B) Inhibiting integrin αVβ6 using neutralizing antibodies (5 μg/ml) prevented IL-10 
production in primary type II lung epithelial cells. *p < .05, compared to ODN and CCN1
(C) Neutralization of integrin αVβ6 reduced the CCN1 induced IL-10 expression in lung 
tissue. Recombinant CCN1 (5 μg) with or without anti-αVβ6 antibody (10 μg) was 
administered into intra nasally and samples were collected after 24h.
(D) Anti-αVβ6 (10 μg), ODN (10 μg), CCN1 (5 μg) and LPS (10 μg) was administered into 
C57/BL6 mice intra nasally. After 24h, BALF was collected. The cell counts and 
differentials were performed using Diff-Quick staining. *p < .05, compared to ODN and 
CCN1
(E) Levels of TNF-α and IL-10 in BALF were measured using ELISA. *p < .05, compared 
to ODN and CCN1
(F) Primary type II lung epithelial cells were pretreated with each integrin signaling inhibitor 
and recombinant CCN1 (1 Pg/ml) was added. After 4h, IL-10 level was measured using 
ELISA. *p < .05, compared to Sham
All Fig.s represented three independent experiments with identical results.
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Fig. 4. CCN1 secretion was regulated by Cav-1
(A) Beas2B cells were treated with ODN (1 μM). After the designated time, CCN1 
(approximately 42kDa), Cav-1, pCav-1 and β-actin was detected using Western Blot 
analysis.
(B) Primary type II lung epithelial cells were isolated from WT and Cav-1−/−mice and 
treated with ODN for 4h. CCN1 was detected using Western Blot analysis (upper panel) and 
ELISA (lower panel)
(C) Beas2B cells were stimulated with ODN (1 μM) in a time-dependent manner. Whole cell 
lysate was incubated with anti-CCN1, anti-Cav-1 and anti-pCav-1 antibodies, respectively, 
followed by incubating with IgG beads for 1h. Samples were then washed 3 times with 
RIPA buffer. Each precipitated protein was detected using Western Blot analysis.
(D) Co-localization CCN1 and pCav-1 after ODN (1 μM) stimulation. CCN1 (FITC) and 
pCav-1 (Cy3) were detected using confocal microscopy.
(E) Specific domain-depleted CCN1 constructs were transfected into Beas2B cells. After 2 
days, cell lysate was subjected to Western Blot analysis using anti-V5, Cav-1 and pCav-1 
antibodies.
(F) LPS±ODN was administered into the WT and Cav-1−/− mice intra-nasally. Differential 
cell count was performed using the Diff-Quick staining. *p < .05, compared to LPS
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(G) TNF-α and IL-10 level in BALF were measured using ELISA. *p < .05, compared to 
LPS+ODN in WT
All Fig.s represented three independent experiments with identical results.
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Fig. 5. Cav-1 phosphorylation and CCN1 secretion were regulated by Src phosphorylation, 
particularly at Y527
(A) Beas2B cells were treated with ODN (1 μM). Src, Src-Y416 and Src-Y527 were 
detected.
(B) Beas2B cells were transfected with Src siRNA. After 2 days, cells were treated with 
ODN (1 μM) for 45 and 60 min. β-actin, Cav-1, pCav-1 and Src were detected using 
Western Blot analysis.
(C) After Src silencing using siRNAs, Beas2B cells were treated with ODN (1 μM) for 4h. 
CCN1 was measured using ELISA.
(D) Beas2B cells were pre-treated with PP2, inhibitor of Src phosphorylation. After 45 or 60 
min, β-actin, Cav-1, pCav-1, Src, Src-Y416 and Src-Y527 were detected.
(E) Beas2B cells were pre-treated with PP2, for 1h, and ODN for 4h. CCN1 was measured 
using ELISA
(F) Co-Immunoprecipitation (Co-IP) assays between Src or CCN1 and pCav-1 in Beas2B 
cells were performed after ODN stimulation in a time-dependent manner.
(G) Specific domain-depleted CCN1 constructs (with V5 tag) were transfected into Beas2B 
cells. After 2 days, V5 and Src were detected using Western Blot analysis.
(H) Beas2B cells were transfected with CCN1 or Cav-1 siRNAs. After 2 days, ODN (1 μM) 
was added. 45 and 60 min after adding ODN, β-actin, Cav-1, CCN1, Src, Src-Y416, Src-
Y527 were detected.
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(I) LPS with or without ODN (1 μM) were administered into C57/BL6 mice intra-nasally. 
PP2 (5 mg/kg) was administrated intra peritoneally. After 24h, BALF was collected. Cell 
counts were assessed. *p < .05, compared to LPS+ODN_Sham
(J) TNF-α and IL-10 level in BALF were measured using ELISA. *p < .05, compared to 
LPS+ODN_Sham
All Fig.s represented three independent experiments with identical results.
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Fig. 6. CpG ODN localized in ER and triggered ER stress
(A) Beas2b cells were treated with CpG ODN-FITC (1 μM). The localization of CpG ODN 
was observed using confocal microscope. Markers for mitochondria, Bcl2; for endosome, 
EEA; for lysosome, LAMP-1; for Golgi, GM130; for ER, BiP/GRP78
(B) Beas2B cells were treated with ODN (1 μM). Within 5 min, calnexin, ERp94, ERp44, 
BiP, CHOP and β-actin was evaluated using Western Blot analysis
(C) Beas2B cells were exposed to each inhibitor. After 1h, cells were exposed to ODN (1 
μM). After additional 4h, CCN1 was measured using ELISA. Inhibitors used for JNK, JNK 
inhibitor; for MAPK, SB 203580; for NF-κB, Bay 11-7082; for Perk, Perk inhibitor; for 
ATF6 activation, γ-secretase inhibitor
(D) Beas2B cells were transfected with BiP or JNK siRNAs. After 2days, cells were then 
treated with ODN (1 μM). After additional 4h, CCN1 was measured using ELISA
(E) Beas2B cells were transfected with BiP siRNA. After 2 days, BiP, Src, Src (Y416) and 
Src (Y527) were detected using Western Blot analysis
(F) Beas2B cells were transfected with BiP or JNK siRNAs, followed by treatment of ODN 
as the above. BiP, JNK, Cav-1, pCav-1 and β-actin were detected
(G) Beas2B cells were transfected with BiP siRNA. After 2 days, whole cell lysate was 
incubated with anti-CCN1 or anti-Src, respectively. Cells were then incubated with IgG 
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beads for 1h and washed out 3 times with RIPA buffer. Each precipitated sample was 
detected using Western Blot analysis.
All Fig.s represented three independent experiments with identical results.
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